Answers are grounded in this paper and cite their sources.
Technical white paper presents a reconstruction framework improving low-dose CT image quality, suggesting future clinical applications.
This technical white paper presents SQK QMEDIC-QMLIR and Quantum Longitudinal Diagnostic Intelligence (QLDI), a reconstruction-first medical imaging framework for low-dose CT (LDCT), fidelity-preserving image reconstruction, and future patient state-space modeling. QMEDIC-QMLIR is designed to improve foundational CT image quality by operating earlier in the reconstruction workflow, using sinogram/projection-domain information when available, rather than relying only on downstream DICOM image post-processing. The framework aims to support artifact reduction, low-contrast detectability, subtle-structure preservation, uncertainty-aware validation, and higher-quality inputs for radiologists and downstream medical AI systems. The white paper describes QMLIR, QPINN, QPR, and QLDI; outlines the platform architecture, Quantum-HPC strategy, clinical validation direction, FDA 510(k) readiness planning, commercialization roadmap, and validation metric framework; and positions QMEDIC as a research-use and development-stage reconstruction-enabling platform for clinically practical LDCT. This document is provided for research collaboration, technical review, and commercialization discussion. QMEDIC is not presented as a cleared or authorized medical device, and any future clinical use would require appropriate validation, regulatory review, and clearance or authorization.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: